CA Stock MarketDetailed Quotes
MIR MedMira Inc
- 0.075
- -0.005-6.25%
15min DelayMarket Closed Nov 26 16:00 ET
52.63MMarket Cap-15000P/E (TTM)
0.080High0.075Low30.00KVolume0.080Open0.080Pre Close2.28KTurnover0.13552wk High0.01%Turnover Ratio701.73MShares0.07052wk Low-0.005EPS TTM16.78MFloat Cap17.500Historical HighLossP/E (Static)223.80MShs Float0.005Historical Low-0.004EPS LYR6.25%Amplitude--Dividend TTM-3.13P/B1Lot Size--Div YieldTTM
MedMira Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -23.08%81.55K | -12.81%148.7K | -2.41%117.86K | -54.57%432.53K | -72.61%35.21K | -67.27%106.01K | -42.67%170.54K | -40.26%120.77K | -55.60%952.13K | 16.51%128.56K |
| Operating revenue | -23.08%81.55K | -12.81%148.7K | -2.41%117.86K | -54.57%432.53K | -72.61%35.21K | -67.27%106.01K | -42.67%170.54K | -40.26%120.77K | -55.60%952.13K | 16.51%128.56K |
| Cost of revenue | -30.19%31.24K | -0.05%80.56K | 109.88%47.23K | -79.61%132.15K | -150.02%-15.71K | -80.31%44.75K | -61.96%80.6K | -87.32%22.5K | 53.31%648.1K | 26.44%31.41K |
| Gross profit | -17.88%50.31K | -24.24%68.14K | -28.12%70.63K | -1.20%300.38K | -47.58%50.92K | -36.59%61.26K | 5.08%89.94K | 297.95%98.27K | -82.34%304.03K | 13.63%97.15K |
| Operating expense | 23.87%653.4K | -5.10%436.29K | 12.17%668.73K | 32.09%2.08M | 27.99%495.13K | 34.40%527.49K | 3.27%459.75K | 70.81%596.15K | -8.29%1.57M | -23.71%386.85K |
| Selling and administrative expenses | -38.94%264.15K | 79.92%302.46K | 76.02%362.22K | 38.58%1.04M | 17.10%232.26K | 152.54%432.59K | -27.76%168.11K | 39.75%205.78K | 40.14%749.58K | -37.21%198.34K |
| -Selling and marketing expense | -65.37%61.42K | 1,707.19%85.48K | 530.44%70.43K | 1,230.29%196.11K | -74.16%2.84K | 4,946.06%177.37K | 1,550.92%4.73K | 1,909.17%11.17K | -66.72%14.74K | 1,477.76%11K |
| -General and administrative expense | -20.57%202.73K | 32.81%216.98K | 49.94%291.79K | 14.67%842.61K | 22.45%229.41K | 52.11%255.22K | -29.89%163.38K | 32.67%194.61K | 49.78%734.83K | -40.56%187.35K |
| Research and development costs | 100.59%194.15K | -28.21%76.36K | -46.81%100.49K | 146.25%470.68K | -34.76%78.62K | 166.50%96.79K | 900.35%106.36K | 296.84%188.92K | -46.81%191.14K | -15.60%120.5K |
| Other operating expenses | 10,461.13%195.1K | -68.98%57.47K | 2.26%206.03K | -10.07%569.11K | 170.92%184.25K | -101.02%-1.88K | -17.94%185.28K | 30.67%201.46K | -22.98%632.85K | 40.47%68.01K |
| Operating profit | -29.35%-603.09K | 0.45%-368.15K | -20.13%-598.1K | -40.06%-1.78M | -53.33%-444.21K | -57.57%-466.23K | -2.84%-369.81K | -53.51%-497.89K | -21,632.23%-1.27M | 31.28%-289.71K |
| Net non-operating interest income (expenses) | -43.08%-177.05K | -84.46%-222.64K | -35.45%-182.26K | -59.69%-897.52K | -198.94%-518.51K | -7.44%-123.75K | -11.01%-120.7K | 18.29%-134.56K | 17.55%-562.04K | 19.47%-173.45K |
| Non-operating interest expense | 43.08%177.05K | 84.46%222.64K | 35.45%182.26K | 60.41%885.52K | 209.89%506.51K | 7.44%123.75K | 11.01%120.7K | -18.29%134.56K | -15.50%552.04K | -12.59%163.45K |
| Total other finance cost | ---- | ---- | ---- | 20.00%12K | ---- | ---- | ---- | ---- | -64.79%10K | ---- |
| Other net income (expenses) | ||||||||||
| Income before tax | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K | -171.02%-1.83M | 27.29%-463.16K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K | -171.02%-1.83M | 27.29%-463.16K |
| Net income continuous operations | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K | -171.02%-1.83M | 27.29%-463.16K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K | -171.02%-1.83M | 27.29%-463.16K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K | -171.02%-1.83M | 27.29%-463.16K |
| Diluted earnings per share | 0.00%-0.001 | 0.00%-0.001 | 0.00%-0.001 | -33.33%-0.004 | -100.00%-0.002 | -66.67%-0.001 | -42.86%-0.001 | 0.00%-0.001 | -200.00%-0.003 | -11.11%-0.001 |
| Basic earnings per share | 0.00%-0.001 | 0.00%-0.001 | 0.00%-0.001 | -33.33%-0.004 | -100.00%-0.002 | -66.67%-0.001 | -42.86%-0.001 | 0.00%-0.001 | -200.00%-0.003 | -11.11%-0.001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data